TYPES OF PATIENTS WITH HYPOTHYROIDISM

Some patients with hypothyroidism can be challenging to treat and require special consideration. Use this section to review the cases of Steve, Jennifer, and Diana to see how to effectively manage their hypothyroidism with SYNTHROID (levothyroxine sodium).

TSH Levels in Men; patient profile 3

Steve, 50

Recently diagnosed patient*

  • Recently diagnosed with hypothyroidism
  • Initiating treatment
Click here to review Steve’s chart
TSH Levels in pregnancy; patient profile 2

Jennifer, 32

Pregnant patient*

  • Diagnosed with hypothyroidism 3 years ago
  • Started and managed on levothyroxine
Click here to review Jennifer’s chart
Hypothyroidism in the elderly; patient profile 1

Diana, 70

Elderly patient*

  • Diagnosed with hypothyroidism 10 years ago
  • Gastroesophageal reflux disease (GERD) diagnosed 6 months ago
Click here to review Diana’s chart

*Hypothetical patient profile.

Recently diagnosed patient*

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
  • Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit.

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantiu.

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.
  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.
  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.

Section Header

  • Sed ut perspiciatis unde

    •  

Steve is a 50-year-old man with hypothyroidism.

TSH Levels in Men; patient profile 3

Past Medical History:

  • 4 months ago, 190-lb patient presented with weight gain of 20 pounds in 1 year. Patient complained of fatigue, dry skin, constipation, cold intolerance, TSH 10.2 mIU/L, BP 150/60, total cholesterol 235 mg/dL; patient was diagnosed with hypothyroidism and started on SYNTHROID 137 mcg
  • 8 weeks later, patient’s complaints continued. TSH 4.6 mIU/L; SYNTHROID dose increased to 150 mcg

Current Complaint:

  • Nervousness, agitation, palpitations, and feeling hot for the past few months

Current Medications:

  • SYNTHROID 150 mcg

Notable Physical Exam and Lab Findings:

  • Sweating profusely despite air-conditioned exam room
  • TSH 0.3 mIU/L

Diagnosis:

  • Patient is displaying symptoms of being overreplaced with current dose of SYNTHROID of 150 mcg; TSH test confirmed

Treatment Plan Considerations:

  • Decrease dose of SYNTHROID
  • Recheck TSH levels in 4-6 weeks

*Hypothetical patient profile.

CLINICAL INSIGHT

  • Managing hypothyroidism requires frequent monitoring

Study of more than 1500 patients found that 40% of patients being treated for hypothyroidism were not within the normal therapeutic TSH range15

COLORADO THYROID DISEASE PREVALENCE STUDY15

60%

Euthyroid†

40%

Outside of therapeutic TSH range

TSH Levels; clinical study data
TSH Levels; clinical study data
TSH Levels; clinical study data

(N=1525) 
Therapeutic TSH range: 0.3-5.1 mIU/L
†Euthyroid=normal thyroid function.

 

Achieving steady TSH levels and hormonal stability requires precise, individualized dosing, and adequate monitoring is essential in stabilizing TSH levels.2

 

  • Under- or overmedicating can have serious effects2
  • With a narrow therapeutic range, even small dose changes in levothyroxine, including SYNTHROID, can affect TSH levels2

THE CARR STUDY: PROOF THAT PRECISE DOSING MATTERS16

Adapted from a 1988 biochemical study conducted in 21 adult Caucasian patients in the United Kingdom with primary hypothyroidism who were tested on a series of different thyroxine dosages to evaluate effectiveness of measuring TSH levels to monitor thyroid function.16

Following a 25-mcg dose change of levothyroxine, most patients had changes in TSH levels.

Adjusting Levothyroxine Dose
Study design
Special considerations

Pregnant Patient*

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
  • Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit.

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantiu.

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.
  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.
  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.

Section Header

  • Sed ut perspiciatis unde

    •  

Jennifer is a 32-year-old woman in her first trimester of pregnancy with
hypothyroidism that is managed on SYNTHROID.

TSH Levels in pregnancy; patient profile 2

Past Medical History:

  • Diagnosed with hypothyroidism 3 years ago
  • Started and managed on 50 mcg SYNTHROID
  • Weight fluctuation
  • Appendectomy

Current Complaint:

  • Fatigue and facial puffiness

Current Medications:

  • SYNTHROID 50 mcg

Notable Physical Exam and Lab Findings:

  • Young woman with cold, dry skin and facial puffiness
  • TSH 6.2 mIU/L

Diagnosis:

  • Patient is displaying symptoms of hypothyroidism due to subtherapeutic dosing of SYNTHROID; TSH test confirmed

Treatment Plan Considerations:

  • Increase dosage of SYNTHROID
  • Recheck TSH levels in 4 weeks

*Hypothetical patient profile.

CLINICAL INSIGHT

TSH levels may increase during pregnancy. TSH should be monitored and SYNTHROID dosage adjusted during pregnancy.

  • 2017 ATA Guidelines state that17:

Between 50% and 85% of treated hypothyroid women need to increase their levothyroxine dosing during pregnancy

See pregnancy guidelines

ELDERLY PATIENT*

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
  • Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit.

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantiu.

Section Header

  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.
  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.
  • Sed ut perspiciatis unde omnis iste natus error sit voluptatem accntiu.

Section Header

  • Sed ut perspiciatis unde

    •  

Diana is a 70-year-old woman who has a history of
hypothyroidism that has been managed on 112 mcg of SYNTHROID for the past 5 years.

Hypothyroidism in the elderly; patient profile 1

Past Medical History:

  • Hypothyroidism diagnosed 10 years ago
  • Gastroesophageal reflux disease (GERD) diagnosed 6 months ago
  • Enlarged thyroid

Current Complaint:

  • Increasing hair loss, fatigue, chronic constipation for the past few months

Current Medications:

  • SYNTHROID 112 mcg
  • Daily fiber supplements
  • Proton pump inhibitor (PPI)

Notable Physical Exam and Lab Findings:

  • Well-nourished elderly woman with thinning hair
  • TSH 5.7 mIU/L

Diagnosis:

  • Patient is displaying symptoms of hypothyroidism (TSH test confirmed), most likely due to the initiation of a PPI and the concurrent use of daily fiber supplements

Treatment Plan Considerations:

  • Counseled patient to take SYNTHROID on an empty stomach and at least 4 hours before or after other medications
  • Recheck TSH levels in 6-8 weeks

*Hypothetical patient profile.

CLINICAL INSIGHT

  • Certain medications, supplements, and foods can affect absorption of levothyroxine, including SYNTHROID2

Gastric acidity is essential for adequate absorption of levothyroxine; therefore, administration of a PPI may affect the intragastric pH, which can reduce absorption

Levothyroxine should be taken on an empty stomach and at least 4 hours before or after medications known to interfere with absorption

Dietary fiber may bind and decrease the absorption of levothyroxine from the gastrointestinal tract

  • The Third National Health and Nutrition Examination Survey (NHANES III) data have shown that the rate of elevated TSH (>4.5 mIU/L) increased with age18
NHANES III; TSH increases with age